+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sarepta Therapeutics - logo

Sarepta Therapeutics is a biopharmaceutical company that focuses on the development of RNA-based therapeutics for the treatment of rare neuromuscular diseases. The company offers EXONDYS 51, a disease-modifying therapy for the treatment of duchenne muscular dystrophy (DMD). It also develops SRP-4045 and SRP-4053, which are exon skipping clinical product candidates for the treatment of DMD. Sarepta Therapeutics, Inc. was founded in 1980 and is headquartered in Cambridge, Massachusetts.

From
From
Oligonucleotide Therapy Market Report 2025 - Product Thumbnail Image

Oligonucleotide Therapy Market Report 2025

  • Report
  • March 2025
  • 250 Pages
  • Global
From
From
Duchenne Muscular Dystrophy - Global Clinical Trials Review, 2024 - Product Thumbnail Image

Duchenne Muscular Dystrophy - Global Clinical Trials Review, 2024

  • Clinical Trials
  • January 2024
  • 257 Pages
  • Global
From
Casimersen - Drug Insight and Market Forecast - 2030 - Product Thumbnail Image

Casimersen - Drug Insight and Market Forecast - 2030

  • Report
  • August 2020
  • 80 Pages
  • Global
From
From
Collaboration Deals in Pharmaceuticals 2019-2025 - Product Thumbnail Image

Collaboration Deals in Pharmaceuticals 2019-2025

  • Report
  • April 2025
  • 950 Pages
  • Global
From
Vaccine Contract Manufacturing Market Report 2023-2033 - Product Thumbnail Image

Vaccine Contract Manufacturing Market Report 2023-2033

  • Report
  • May 2023
  • 375 Pages
  • Global
From
From
From
Translational Regenerative Medicine Market Report 2024-2034 - Product Thumbnail Image

Translational Regenerative Medicine Market Report 2024-2034

  • Report
  • February 2024
  • 270 Pages
  • Global
From
Loading Indicator